India's Everest Organics starts making molnupiravir drug ingredient
12/10/2021 07:09
BENGALURU, Oct 12 (Reuters) - Indian bulk drugs manufacturer Everest Organics Ltd EVER.BO said on Tuesday it had started making the active pharmaceutical ingredient for a generic version of Merck & Co's MRK.N promising antiviral drug molnupiravir to treat mild to moderate COVID-19. (Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Subhranshu Sahu) ((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))
Recent news on Everest Organics
See all newsBrief: Everest Organics Gets Korea Drug Master File Approval For Its Rabeprazole Sodium API
Brief: Everest Organics To Consider Fund Raising
Brief: Everest Organics Names Srikakarlapudi Sirisha As MD
Brief: Everest Organics Gets Permanent Revocation Of Factory Closure Order
India's Everest Organics starts making ingredient for Merck's COVID-19 pill (updated)